戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 nduce the invasive infection associated with bubonic plague.
2 increased virulence and the emergence of the bubonic plague.
3 contributes to disease in the mouse model of bubonic plague.
4 hese MPs significantly increased survival of bubonic plague.
5 play an important role in the progression of bubonic plague.
6 el; however, it was attenuated in developing bubonic plague.
7 med to be important for the establishment of bubonic plague.
8  with antibody therapy in the mouse model of bubonic plague.
9 mination during pneumonic plague than during bubonic plague.
10 imic transmission by fleabite, leads only to bubonic plague.
11  rat closely resembled descriptions of human bubonic plague.
12 es, ranging from food-borne illnesses to the bubonic plague.
13  been proposed to provide protection against bubonic plague.
14 se that is an essential virulence factor for bubonic plague.
15 s ranging from gastrointestinal syndromes to Bubonic Plague.
16 o its current frequency can be attributed to bubonic plague.
17 s ranging from gastrointestinal syndromes to bubonic plague.
18 significantly attenuated in a mouse model of bubonic plague.
19 ifferent stages of the infectious process of bubonic plague.
20 f infection that mimics flea transmission of bubonic plague.
21 r of Yersinia pestis, the causative agent of bubonic plague.
22                       Yersinia pestis causes bubonic plague, a fulminant disease where host immune re
23 ions to study bacterial dissemination during bubonic plague and compare this model with an s.c. inocu
24 antibody responses that protect mice against bubonic plague and pneumonic plague, suggesting that rV1
25    Yersinia pestis is the causative agent of bubonic plague and possesses a set of plasmid-encoded, s
26 tigations into the molecular pathogenesis of bubonic plague and the immune response to Y. pestis at d
27 f new vaccines to prevent naturally acquired bubonic plague and to study events at the vector-host in
28  exhibited an exceptional capacity to resist bubonic plague and used it to identify immune mechanisms
29 nt resulted in an atypical, subacute form of bubonic plague associated with extensive recruitment of
30 e clusters are present in the genomes of the bubonic plague bacillus Yersinia pestis and the human an
31                          Yersina pestis, the bubonic plague bacterium, is coated with a polymeric pro
32  superfamily, is an effector produced by the bubonic plague bacterium, Yersinia pestis, that is essen
33                Yersinia pestis, the cause of bubonic plague, blocks feeding by its vector, the flea.
34  cells and a large decrease in virulence for bubonic plague but not for pneumonic plague in mice.
35 , spatial metapopulation model, we show that bubonic plague can persist in relatively small rodent po
36  use provides significant protection against bubonic plague caused by an F1- strain (C12) or against
37                          In a mouse model of bubonic plague, CCR2 also was shown to be required for D
38 in combination, conferred protection against bubonic plague challenge in mice.
39                       Yersinia pestis causes bubonic plague, characterized by an enlarged, painful ly
40 ia pestis is transmitted by fleas and causes bubonic plague, characterized by severe local lymphadeni
41 the more biologically relevant i.d. model of bubonic plague differs significantly from the s.c. model
42 gory BSL 3 and 4 pathogens, such as anthrax, bubonic plague, Ebola and Marburg fever.
43                Yersinia pestis, the agent of bubonic plague, evolved from the enteric pathogen Yersin
44                             A mouse model of bubonic plague failed to show a significant role for the
45 le of Yersinia pestis YopJ in a rat model of bubonic plague following intradermal infection with a fu
46 uring infection, but the role of YopJ during bubonic plague has not been completely established.
47 ull pathogenic ability in both pneumonic and bubonic plague in C57BL/6J mice.
48                                              Bubonic plague in humans follows transmission by infecte
49 ntly caught ill-prepared societies off-guard-Bubonic plague in medieval times, AIDS in the 1980s, and
50 ugh flea-borne transmission usually leads to bubonic plague in mice, it can also lead to primary sept
51 adermal model, suggesting a role for YopM in bubonic plague, in which acute inflammation occurs soon
52 in macrophages and for virulence in a murine bubonic plague infection assay.
53           Here, the historical background of bubonic plague is briefly described and recent studies i
54 ional human-disease models, and propose that bubonic plague is driven by the dynamics of the disease
55                              The hallmark of bubonic plague is the presence of grotesquely swollen ly
56                                              Bubonic plague is transmitted by fleas whose feeding is
57                                              Bubonic plague is transmitted by fleas whose feeding is
58                                              Bubonic plague is transmitted to mammals, including huma
59                                              Bubonic plague is widely regarded as a disease of mainly
60 s of Yersinia pestis, the causative agent of bubonic plague, is the yersiniabactin (Ybt) siderophore-
61 lence of Yersinia pestis, causative agent of bubonic plague, is the yersiniabactin (Ybt) siderophore-
62                Yersinia pestis, the cause of bubonic plague, is transmitted by the bites of infected
63                                          For bubonic plague, mice dosed with Salmonella-(F1+V)Ags and
64 Brown Norway rat was recently described as a bubonic plague model that closely mimics human disease.
65 tially avirulent via subcutaneous injection (bubonic plague model).
66 tive to the Yfe(+) Feo(+) parent strain in a bubonic plague model.
67                                              Bubonic plague, one of history's deadliest infections, i
68 pestis against complement-mediated lysis, on bubonic plague pathogenesis in mice and rats.
69 ults indicate that YopJ is not essential for bubonic plague pathogenesis, even after peripheral inocu
70 large-scale food-borne illnesses, dysentery, bubonic plague, secondary hospital infections, and sexua
71      Yersinia pestis, the causative agent of bubonic plague, secretes a eukaryotic-like protein tyros
72 ons, we analyze the full ecoepidemiological (bubonic) plague system.
73 indicating a more important role for RovA in bubonic plague than pneumonic plague or systemic infecti
74 past because it provided protection against (bubonic) plague; the mutation, called CCR5Delta32, is ch
75 ases explored include tuberculosis, leprosy, bubonic plague, typhoid, syphilis, endemic and epidemic
76                      We developed a model of bubonic plague using the inbred Brown Norway strain of R
77    The Y. pestis Ail protein is an important bubonic plague virulence factor that inhibits the innate
78                         Using a rat model of bubonic plague, we examined lymph node histopathology, t
79  septicemic plague at low incidence, but not bubonic plague, when transmitted by fleas.
80  and Yersinia pestis, the causative agent of bubonic plague, which has a flea vector.
81 on at 8 LD50 when tested in a mouse model of bubonic plague, with infection by 10/20 of the aforement
82  LcrV in the passive transfer of immunity to bubonic plague, with multiple neutralizing epitopes in L
83 y to control malaria, typhus, body lice, and bubonic plague worldwide, until countries began restrict
84 a from the catastrophic European Black Death/bubonic plague (Yersinia pestis).
85                       The etiologic agent of bubonic plague, Yersinia pestis, senses self-produced, s

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。